A Comprehensive Review and Evaluation of the Diagnostic Methods of a Multiple System Atrophy Diagnosis
DOI:
https://doi.org/10.58445/rars.1508Keywords:
multiple system atrophy, diagnosis, movement disorders, neuroscienceAbstract
Multiple System Atrophy (MSA) is a rare neurodegenerative disorder, characterized by the accumulation of α-synuclein in oligodendrocytes, often misdiagnosed with Parkinson's Disease (PD) due to overlapping symptoms. This study reviews the diagnostic methods used for MSA and discusses their benefits and how they can be improved for future research. Through a comprehensive search of the current literature, utilizing PubMed and Google Scholar, I analyzed and compiled numerous research articles for their relevance and content. Current diagnostic methods include diagnostic criteria, biomarkers, and genetic screening; these methods allow clinicians to identify individuals with MSA from healthy individuals. However, there is not yet substantial research toward concrete guidelines distinguishing MSA from other disorders. While several promising techniques are being studied, they have primarily addressed identifying a movement disorder. Accurately diagnosing MSA does not stop there: studies must also be consistent in measuring data from MSA and PD patients to establish categorical use. Generally, studies have found that MSA symptoms present more severely, but concrete numbers should be developed in order to categorize a patient as MSA, PD, or some other disorder. Should clinicians come across a patient with a movement disorder, data taken from the patient must point to either MSA or PD. Further exploring these methods will help identify variations between MSA and PD in symptoms, disease risk, and disease severity ⎯ all of which will improve upon symptom management and disease treatment. Emphasizing the accurate and distinctive diagnosis of MSA allows individuals to better manage the severe consequences of this devastating disease.
References
Abdul‐Rahman, T., Herrera‐Calderón, R. E., Ahluwalia, A., Wireko, A. A., Ferreira, T., Tan, J. K., Wolfson, M., Ghosh, S., Horbas, V., Garg, V., Perveen, A., Papadakis, M., Ashraf, G. M., & Alexiou, A. (2024). The potential of phosphorylated α‐synuclein as a biomarker for the diagnosis and monitoring of multiple system atrophy. CNS Neuroscience & Therapeutics, 30(4). https://doi.org/10.1111/cns.14678
Al-Chalabi, A., Dürr, A., Wood, N. W., Parkinson, M. H., Camuzat, A., Hulot, J. S., Morrison, K. E., Renton, A., Sussmuth, S. D., Landwehrmeyer, B. G., Ludolph, A., Agid, Y., Brice, A., Leigh, P. N., Bensimon, G., & NNIPPS Genetic Study Group (2009). Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy. PloS one, 4(9), e7114. https://doi.org/10.1371/journal.pone.0007114
Burns, M. R., & McFarland, N. R. (2020). Current Management and Emerging Therapies in Multiple System Atrophy. Neurotherapeutics, 17(4), 1582–1602. https://doi.org/10.1007/s13311-020-00890-x
Butler, B., Sambo, D., & Khoshbouei, H. (2017). Alpha-synuclein modulates dopamine neurotransmission. Journal of chemical neuroanatomy, 83-84, 41–49. https://doi.org/10.1016/j.jchemneu.2016.06.001
Chen, Y. P., Zhao, B., Cao, B., Song, W., Guo, X., Wei, Q. Q., Yang, Y., Yuan, L. X., & Shang, H. F. (2015). Mutation scanning of the COQ2 gene in ethnic Chinese patients with multiple-system atrophy. Neurobiology of Aging, 36(2), 1222.e7-1222.e11. https://doi.org/10.1016/j.neurobiolaging.2014.09.010
Donadio, V., Incensi, A., Rizzo, G., Westermark, G. T., Devigili, G., De Micco, R., Tessitore, A., Nyholm, D., Parisini, S., Nyman, D., Tedeschi, G., Eleopra, R., Ingelsson, M., & Liguori, R. (2023). Phosphorylated α-synuclein in skin Schwann cells: a new biomarker for multiple system atrophy. Brain, 146(3), 1065–1074. https://doi.org/10.1093/brain/awac124
Doppler, K., Weis, J., Karl, K., Ebert, S., Ebentheuer, J., Trenkwalder, C., Klebe, S., Volkmann, J., & Sommer, C. (2015). Distinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophy. Movement Disorders, 30(12), 1688–1692. https://doi.org/10.1002/mds.26293
Foulds, P. G., Yokota, O., Thurston, A., Davidson, Y., Ahmed, Z., Holton, J., Thompson, J. C., Akiyama, H., Arai, T., Hasegawa, M., Gerhard, A., Allsop, D., & Mann, D. M. (2012). Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies. Neurobiology of disease, 45(1), 188–195. https://doi.org/10.1016/j.nbd.2011.08.003
Hara, K., Momose, Y., Tokiguchi, S., Shimohata, M., Terajima, K., Onodera, O., Kakita, A., Yamada, M., Takahashi, H., Hirasawa, M., Mizuno, Y., Ogata, K., Goto, J., Kanazawa, I., Nishizawa, M., & Tsuji, S. (2007). Multiplex families with multiple system atrophy. Archives of neurology, 64(4), 545–551. https://doi.org/10.1001/archneur.64.4.545
Jellinger K. A. (2022). Heterogeneity of Multiple System Atrophy: An Update. Biomedicines, 10(3), 599. https://doi.org/10.3390/biomedicines10030599
Katzeff, J. S., Phan, K., Purushothuman, S., Halliday, G. M., & Kim, W. S. (2019). Cross-examining candidate genes implicated in multiple system atrophy. Acta Neuropathologica Communications, 7(1). https://doi.org/10.1186/s40478-019-0769-4
Labbé, C., Heckman, M. G., Lorenzo-Betancor, O., Murray, M. E., Ogaki, K., Soto-Ortolaza, A. I., Walton, R. L., Fujioka, S., Koga, S., Uitti, R. J., van Gerpen, J. A., Petersen, R. C., Graff-Radford, N. R., Younkin, S. G., Boeve, B. F., Cheshire, W. P., Jr, Low, P. A., Sandroni, P., Coon, E. A., Singer, W., … Ross, O. A. (2016). MAPT haplotype diversity in multiple system atrophy. Parkinsonism & related disorders, 30, 40–45. https://doi.org/10.1016/j.parkreldis.2016.06.010
Li, X. Y., Yang, W., Li, X., Li, X. R., Li, W., Song, Q., Sun, L., Lin, F., Chen, Z., Wang, C., & Yu, S. (2020). Phosphorylated Alpha-Synuclein in Red Blood Cells as a Potential Diagnostic Biomarker for Multiple System Atrophy: A Pilot Study. Parkinson's disease, 2020, 8740419. https://doi.org/10.1155/2020/8740419
Monzio Compagnoni, G., Kleiner, G., Bordoni, A., Fortunato, F., Ronchi, D., Salani, S., Guida, M., Corti, C., Pichler, I., Bergamini, C., Fato, R., Pellecchia, M. T., Vallelunga, A., Del Sorbo, F., Elia, A., Reale, C., Garavaglia, B., Mora, G., Albanese, A., . . . Di Fonzo, A. (2018). Mitochondrial dysfunction in fibroblasts of Multiple System Atrophy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1864(12), 3588-3597. https://doi.org/10.1016/j.bbadis.2018.09.018
Multiple-System Atrophy Research Collaboration (2013). Mutations in COQ2 in familial and sporadic multiple-system atrophy. The New England journal of medicine, 369(3), 233–244. https://doi.org/10.1056/NEJMoa1212115
Osaki, Y., Wenning, G. K., Daniel, S. E., Hughes, A., Lees, A. J., Mathias, C. J., & Quinn, N. (2002). Do published criteria improve clinical diagnostic accuracy in multiple system atrophy?. Neurology, 59(10), 1486–1491. https://doi.org/10.1212/01.wnl.0000028690.15001.00
Overk, C., Rockenstein, E., Valera, E., Stefanova, N., Wenning, G., & Masliah, E. (2018). Multiple system atrophy: experimental models and reality. Acta neuropathologica, 135(1), 33–47. https://doi.org/10.1007/s00401-017-1772-0
Sailer, A., Scholz, S. W., Nalls, M. A., Schulte, C., Federoff, M., Price, T. R., Lees, A., Ross, O. A., Dickson, D. W., Mok, K., Mencacci, N. E., Schottlaender, L., Chelban, V., Ling, H., O’Sullivan, S. S., Wood, N. W., Traynor, B. J., Ferrucci, L., Federoff, H. J., . . . Cortelli, P. (2016). A genome-wide association study in multiple system atrophy. Neurology, 87(15), 1591–1598. https://doi.org/10.1212/wnl.0000000000003221
Sekiya, H., Kowa, H., Koga, H., Takata, M., Satake, W., Futamura, N., Funakawa, I., Jinnai, K., Takahashi, M., Kondo, T., Ueno, Y., Kanagawa, M., Kobayashi, K., & Toda, T. (2019). Wide distribution of alpha-synuclein oligomers in multiple system atrophy brain detected by proximity ligation. Acta Neuropathologica, 137(3), 455–466. https://doi.org/10.1007/s00401-019-01961-w
Shahnawaz, M., Mukherjee, A., Pritzkow, S., Mendez, N., Rabadia, P., Liu, X., Hu, B., Schmeichel, A., Singer, W., Wu, G., Tsai, A. L., Shirani, H., Nilsson, K. P. R., Low, P. A., & Soto, C. (2020). Discriminating α-synuclein strains in Parkinson's disease and multiple system atrophy. Nature, 578(7794), 273–277. https://doi.org/10.1038/s41586-020-1984-7
Soma, H., Yabe, I., Takei, A., Fujiki, N., Yanagihara, T., & Sasaki, H. (2006). Heredity in multiple system atrophy. Journal of the neurological sciences, 240(1-2), 107–110. https://doi.org/10.1016/j.jns.2005.09.003
Sun, Z., Ohta, Y., Yamashita, T., Sato, K., Takemoto, M., Hishikawa, N., & Abe, K. (2016). New susceptible variant of COQ2 gene in Japanese patients with sporadic multiple system atrophy. Neurology. Genetics, 2(2). https://doi.org/10.1212/nxg.0000000000000054
Sun, Z., Xiang, X., Tang, B., Chen, Z., Peng, H., Xia, K., & Jiang, H. (2015). SNP rs11931074 of the SNCA gene may not be associated with multiple system atrophy in Chinese population. The International journal of neuroscience, 125(8), 612–615. https://doi.org/10.3109/00207454.2014.990013
Takado, Y., Igarashi, H., Terajima, K., Shimohata, T., Ozawa, T., Okamoto, K., Nishizawa, M., & Nakada, T. (2011). Brainstem metabolites in multiple system atrophy of cerebellar type: 3.0-T magnetic resonance spectroscopy study. Movement disorders : official journal of the Movement Disorder Society, 26(7), 1297–1302. https://doi.org/10.1002/mds.23550
Tseng, F. S., Foo, J. Q. X., Mai, A. S., & Tan, E. K. (2023). The genetic basis of multiple system atrophy. Journal of translational medicine, 21(1), 104. https://doi.org/10.1186/s12967-023-03905-1
Wan, L., Zhu, S., Chen, Z., Qiu, R., Tang, B., & Jiang, H. (2023). Multidimensional biomarkers for multiple system atrophy: an update and future directions. Translational neurodegeneration, 12(1), 38. https://doi.org/10.1186/s40035-023-00370-0
Watanabe, H., Shima, S., Mizutani, Y., Ueda, A., & Ito, M. (2023). Multiple System Atrophy: Advances in Diagnosis and Therapy. Journal of movement disorders, 16(1), 13–21. https://doi.org/10.14802/jmd.22082
Wenning, G. K., Stankovic, I., Vignatelli, L., Fanciulli, A., Calandra-Buonaura, G., Seppi, K., Palma, J. A., Meissner, W. G., Krismer, F., Berg, D., Cortelli, P., Freeman, R., Halliday, G., Höglinger, G., Lang, A., Ling, H., Litvan, I., Low, P., Miki, Y., Panicker, J., … Kaufmann, H. (2022). The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy. Movement disorders : official journal of the Movement Disorder Society, 37(6), 1131–1148. https://doi.org/10.1002/mds.29005
Downloads
Posted
Categories
License
Copyright (c) 2025 Ria Nabar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.